Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
Yeda Research and Development Co. Ltd.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 19 of these applications claim priority to application PCT/IL2015/050265, filed Mar 12, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,394,365 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | ||
| US 9,512,225 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | ||
| US 9,512,227 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease In force · High confidence | Yeda Research and Development Co., Ltd. | In force | High confidence | ||
| US 9,534,052 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease In force · High confidence | Yeda Research and Development Co., Ltd. | In force | High confidence | ||
| US 9,856,318 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS In force · High confidence | Yeda Research and Development Co. Ltd. | In force | High confidence | ||
| US 9,982,047 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease In force · High confidence | Yeda Research and Development Co., Ltd. | In force | High confidence | ||
| US 9,982,048 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease In force · High confidence | Yeda Research and Development Co., Ltd. | In force | High confidence | ||
| US 9,982,049 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease In force · High confidence | Yeda Research and Development Co., Ltd. | In force | High confidence | ||
| US 9,982,050 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Alzheimer's Disease In force · High confidence | Yeda Research and Development Co., Ltd. | In force | High confidence | ||
| US 9,982,051 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS In force · High confidence | Yeda Research and Development Co., Ltd. | In force | High confidence | ||
| 12 more patents in this group · Pro | ||||||
10 of 22 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 22.
20 of these are in force and held by Yeda Research and Development Co. Ltd..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.